The progesterone receptor regulates the expression of TRPV4 channel.

Laboratory of Molecular Physiology and Channelopathies, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Edifici PRBB, Parc de Recerca Biomèdica de Barcelona, Room 343, C/Dr. Aiguader 88, Barcelona, 08003, Spain.
Pflügers Archiv - European Journal of Physiology (Impact Factor: 3.07). 09/2009; 459(1):105-13. DOI: 10.1007/s00424-009-0706-7
Source: PubMed

ABSTRACT The transient receptor potential cationic channel TRPV4 contributes to different aspects of cell physiology via the generation of a Ca2+ signal and/or depolarization of the membrane potential. TRPV4 channel integrates distinct physical and chemical stimuli, including osmotic and mechanical stress, heat, acidic pH, endogenous ligands, and synthetic agonists such as 4alpha-phorbol 12,13-didecanoate (4alphaPDD). Although several regulatory sites controlling TRPV4 channel activity have been identified, very little is known about the regulation of TRPV4 expression, a situation common to other TRP channels. Here we show that TRPV4 expression is under the control of progesterone in both human airways and mammary gland epithelial cells, as well as in vascular smooth muscle cells. Exposure of human airways epithelial CFT1-LCFSN and mammary gland epithelial T47D cells to progesterone decreased TRPV4 mRNA and protein expression. Consequently, 4alphaPDD-induced cationic currents and Ca2+ signals were also diminished in progesterone-treated cells. The effect of progesterone was reverted by the progesterone receptor (PR) antagonist RU-486 or following transfection with small interference RNA (siRNA) against both PRA and PRB isoforms. Interestingly, TRPV4 expression and activity were increased in T47D mammary gland epithelial cells when PR was silenced with siRNA. Transcriptional regulation of -1.3 kB TRPV4 promoter-luciferase plasmids was also evaluated in vascular smooth muscle cells. TRPV4 promoter activity was reduced by coexpression with PR and further reduced in the presence of PG. Together, our data report the regulation of TRPV4 expression by progesterone, a process that requires a functional PR.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ca(2+) influx through Ca(2+) permeable ion channels is a key trigger and regulator of a diverse set of cellular events, such as neurotransmitter release and muscle contraction. Ca(2+) influx is also a regulator of processes relevant to cancer, including cellular proliferation and migration. This review focuses on calcium influx in breast cancer cells as well as the potential for pharmacological modulators of specific Ca(2+) influx channels to represent future agents for breast cancer therapy. Altered expression of specific calcium permeable ion channels is present in some breast cancers. In some cases, such changes can be related to breast cancer subtype and even prognosis. In vitro and in vivo models have now helped identify specific Ca(2+) channels that play important roles in the proliferation and invasiveness of breast cancer cells. However, some aspects of our understanding of Ca(2+) influx in breast cancer still require further study. These include identifying the mechanisms responsible for altered expression and the most effective therapeutic strategy to target breast cancer cells through specific Ca(2+) channels. The role of Ca(2+) influx in processes beyond breast cancer cell proliferation and migration should become the focus of studies in the next decade.
    British Journal of Pharmacology 02/2014; 171(4):945-60. DOI:10.1111/bph.12486 · 4.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer is a disease with marked heterogeneity in both response to therapy and survival. Clinical and histopathological characteristics have long determined prognosis and therapy. The introduction of molecular diagnostics has heralded an explosion in new prognostic factors. Overall, histopathology, immunohistochemistry and molecular biology techniques have described important new prognostic subgroups in the different cancer categories. Ion channels and transporters (ICT) are a new class of membrane proteins which are aberrantly expressed in several types of human cancers. Besides regulating different aspect of cancer cell behavior, ICT can now represent novel cancer biomarkers. A summary of the data obtained so far and relative to breast, prostate, lung, colorectal, esophagus, pancreatic and gastric cancers are reported. Special emphasis is given to those studies aimed at relating specific ICT or a peculiar ICT profile with current diagnostic methods. Overall, we are close to exploit ICTs for diagnostic, prognostic or predictive purposes in cancer. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers. Copyright © 2014. Published by Elsevier B.V.
    Biochimica et Biophysica Acta (BBA) - Biomembranes 12/2014; DOI:10.1016/j.bbamem.2014.12.016 · 3.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The metabolic activitiesactivity of articular chondrocytes areis influenced by osmotic alterations inthat occur in articular cartilage occurs secondary to mechanical loads. The mechanismskey membrane transporter that sense and transduce mechanical signals fromthe cell swelling and initiatemediate volume regulatory ion isare poorly understood. The purpose of this study was to investigate how the expression of two putativepotential osmolyte channels (TRPV4 and BKCa) in chondrocytes is modulated in different osmotic conditions and totheir interaction examine a potential role for with MAPKss in this processpathways. Isolated equine articular chondrocytes were subjected to anisosmotic conditions and and the expression of the TRPV4 and, BKCa channels and also ERK1/2 and p38 MAPKs protein phosphorylations were investigated using western blotting. Results indicated that This study indicated to the contribution of TRPV4 contributes toin the early stages of hypo-osmotic stress, while BKCa is involved in providing a feedback to the responses to elevatedion of intracellular Ca(2+) and mediated mediating regulatory volume decrease (the RVD) response. ERK1/2 is phosphorylated by hypo-osmotic stress (P<0.001), and p38 MAPK is phosphorylated by hyper-osmotic stress (P<0.001). In addition this study showeddemonstrated the importance of endogenous ERK1/2 phosphorylation in the expression of TRPV4 channel where blocking ERK1/2 by specific inhibitor (PD89059) significantly decreased the endogenous level of the TRPV4 channel in cells exposed to at hypo-osmotic stress and below endogenous levels in at iso-osmotic conditionsstress (P<0.001). It also showed the importance of ERK1/2 phosphorylation in the expression of endogenous levels of TRPV4 channel.
    AJP Cell Physiology 03/2014; 306(11). DOI:10.1152/ajpcell.00287.2013 · 3.67 Impact Factor